Synthesis, characterization, antimicrobial, and DNA cleavage studies of metal complexes of coumarin Schiff bases

Medicinal Chemistry Research

Volumn 20, Issue 4, 2011, Pages 493-502

  Phaniband, Mohammedshafi A ^a   Dhumwad, Shreedhar D ^a   Pattan, Shashikanth R ^b  

^a KARNATAK UNIVERSITY   (India)

^b K L E S S COLLEGE OF PHARMACY   (India)

Author keywords

Coumarin; Cytotoxic activities; DNA cleavage; Fluorescent complexes; Microbial; Tubercular

Indexed keywords

COBALT COMPLEX; COPPER COMPLEX; COUMARIN DERIVATIVE; HYMECROMONE DERIVATIVE; NICKEL COMPLEX; SCHIFF BASE; UNCLASSIFIED DRUG; ZINC COMPLEX;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; DNA CLEAVAGE; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 80052021303     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-010-9343-0     Document Type: Article

References (27)

1. Alcock NW, Tracy VM, Waddington TC (1979) Hydrolysis of cyclopentadienyl zirconium complexes containing chelate ligands. J Chem Soc Dalton Trans 21:2243
2. Bagihalli GB, Avaji PG, Patil SA, Badam PS (2008) Synthesis, spectral characterization, in vitro antibacterial, antifungal and cytotoxic activities of Co(II), Ni(II) and Cu(II) complexes with 1, 2, 4-triazole Schiff bases. Eur J Med Chem 43(12):2639-2649
3. Bentiss F, Lagrenee M, Wignacourt JP, Holt EM (2002) Complexes of cobalt(II), nickel(II) and copper(II) with a thia ligand; 2, 5-bis(2-pyridyl)-1, 3, 4-thiadiazole: structural identification. Polyhedron 21(4):403-408
4. Clause GW (1989) Understanding microbes: a laboratory textbook for microbiology. W.H. Freeman and Company, New York.
5. El-Ansary AL, Omar MM (1988) New lanthanide complexes of 4-methyl-7-hydroxycoumarin and their pharmacological activity. Egypt J Chem 31:511-520
6. Elmer WK, Stephen DA, William MJ, Paul CS, Washing CW Jr (2002) Text book of diagnostic microbiology, 5th edn. Lippincott, Philadelphia
7. Finney DJ (1971) Probit analysis, 3rd edn. Cambridge University Press, Cambridge.
8. Freedman DA, Keresztes I, Asbury AL (2002) Dimethylplatinum (II) complexes with isocyanocoumarin ligands: the crystal structure of cis-dimethylbis-(7-diethylamino-3-isocyanocoumarin)platinum( II). J Organomet Chem 642:97-106
9. Karaliota A, Kretsi O, Tzougraki C (2001) Synthesis and characterization of a binuclear coumarin-3-carboxylate copper(II) complex. J Inorg Biochem 84:33-37 (Pubitemid 32273534)
10. Kawaii S, Tomono Y, Ogawa K, Sugiura M, Yano M, Yoshizawa Y (2001) New samarium(III), gadolinium(III), and dysprosium(III) complexes of coumarin-3-carboxylic acid as antiproliferative agents. Anticancer Res 21:917-923
11. Kirkiacharian S, Thuy DT, Sicsic S, Bakhchinian R, Kurkjian R, Tonnaire T (2002) Reaction between dialkyl acetylenedicarboxylates and six-membered 1, 3-diketones in the presence of trialkylamines: a convenient synthesis of alkyl 2, 5-dioxo-5, 6, 7, 8-tetrahydro-2H-chromene-4-carboxylates. II Farmaco 57: 703-708
12. Mandakmare AU, Navwade ML (1997) Antineoplastic activity of new lanthanide (cerium, lanthanum and neodymium) complex compounds. Orient J Chem 13:155-158
13. Marshall ME, Butler K, Fried A (1991) Synthesis, characterization, and cytotoxic activity of new lanthanum(III) complexes of biscoumarins. Mol Biother 3:170-178
14. Marshall EM, Ryles M, Butler K, Weiss L (1994) New samarium(III), gadolinium(III), and dysprosium(III) complexes of coumarin-3- carboxylic acid as antiproliferative. Agents J Cancer Res Clin Oncol 120:535-538
15. Mohler JL, Williams BT, Thompson IM, Marshall ME (1994) Coumarin (1, 2-benzopyrone) for the treatment of prostatic carcinoma. J Cancer Res Clin Oncol 120:35-38
16. National Committee for Clinical Laboratory Standards (1997) Reference method for broth dilution antifungal susceptibility testing for yeasts; approved standard Document M27-A, Villanova, National Committee for Clinical Laboratory Standards 17, pp 1-29
17. Prasad RN, Mathur M (2002) Synthesis characterization of Cr(III), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) complexes of 2, 12-dimethyl-3-13-di- n-propyl-l, 4, 11, 14-tetraazacycloeicosa-1, 13, 11, 13-tetraene. J Serb Chem Soc 67:825-832
18. Sakyan I, Logoglu E, Sari N, Akiyan N (2004) Metal-based antibacterial and antifungal agents: synthesis, characterization, and in vitro biological evaluation of Co(II), Cu(II), Ni(II), and Zn(II) complexes with amino acid-derived compounds. Biometals 17(2):120
19. Sardari S, Mori Y, Horita K, Micetich RG, Nishibe S, Daneshtalab M (1999) Synthesis and antifungal activity of coumarins and angular furanocoumarins. Bioorg Med Chem 7:1933-1937
20. Singh HB (1980) Stability of the complexes of some lanthanides with coumarin derivatives. I. Cerium(III)-4-methyl-7-hydroxycoumarin. Acta Cienc Indica Ser Chem 6:88-91
21. Spath E, Pailer M (1935) Synthesis, spectral characterization, in vitro antibacterial, antifungal and cytotoxic activities of Co(II), Ni(II) and Cu(II) complexes with 1, 2, 4-triazole Schiff bases. Chem Ber 68:940
22. Teotia MP, Rastogi DK, Malik WU (1973) New lanthanide complexes of 4-methyl-7-hydroxycoumarin and their pharmacological activity. Inorg Chim Acta 7:339-344
23. Thornes RD, Daly L, Lynch G (1994) 4-Hydroxycoumarin disorganizes the actin cytoskeleton in B16-F10 melanoma cells but not in B82 fibroblasts, decreasing their adhesion to extracellular matrix proteins and motility. J Cancer Res Clin Oncol 120:32-34
24. Ul-Hassan M, Chohan ZH, Supuran CT (2002) In vitro antibacterial, antifungal and cytotoxic properties of sulfonamide-derived Schiff's bases and their metal complexes. Main Group Met Chem 25:291
25. Wei YB, Yang P (2005) DNA Cleavage of the copper(II) complexes with a polyamine ditopic ligand. Chin Chem Lett 16(4):537-540 (Pubitemid 43872395)
26. Yu D, Suzuki M, Xie L, Morris-Natschke SL, Lee KH (2003) Anti- AIDS agents. Part 62: anti-HIV activity of 20-substituted 4-methyl- 30, 40-di-O-(-)-camphanoyl-(?)-cis-khellactone (4-methyl DCK) analogs. Med Res Rev 23:322-345
27. Zhao H, Neamati N, Hong H, Mazumder A (1997) HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors. J Med Chem 40:242-249